Clinical Pharmacology
Welcome to Stellenbosch University

Division of Clinical Pharmacology

Publications 2015

1.  Kerpel-Fronius S, Rosenkranz B, Allen E, Bass R, Mainard JD, Dodoo A, Dubois DJ, Hela M, Kern S, Massud J, Silva H, Whitty J. Education and training for medicines development, regulation, and clinical research in emerging countries. Frontiers in Pharmacology 2015; 6: 1 – 8.

2.  Ticha LA, Klaasen JA, Green IR, Naidoo S, Baker B, Pietersen R. Phytochemical and Antimicrobial Screening of Glavanones and Chalcones from Galenia Africana and Dicerothamnus rhinocerotis. Natural product communication 2015; 10(7): 1185-1190.

3.  Dhoro M, Zvada S, Ngara B, Nhachi C, Kadzirange G, Chonzi P, Masimirembwa C. CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modelling in and HIV/AIDS and TB cohort in Zimbabwe. BMC Pharmacology & Toxicology 2015; 16(4): 1 – 10.

4.  Ying Q, Naidoo S, Vaivars G. Function of titanium oxide coated on carbon nanotubes as support for platinum catalysts. Physica Scripta 90(9), 094021.

5.  Awortwe C, Manda VK, Avonto C, Khan SI, Khan IA, Walker LA, Bouic PJ, Rosenkranz B. Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway. Xenobiotica 2015, 45(3): 218-229.

6.  Awortwe C, Manda VK, Avonto C, Khan SI, Khan IA, Walker LA, Bouic PJ, Rosenkranz B. In Vitro evaluation of Reversible and Time-Dependent inhibitory effects of Kalanchoe Crenata on CYP2C19 and CYP3A4 activity. Drug Metabolish Letter 2015; 9: 48-62.

7.  Sy SKB, Malmberg R, Matsushima A, Asin-Prieto E, Rosenkranz B, Cotton MF, Derendorf H, Innes S. Effect of reducing the paediatric stavudine dose by half: A physiolgogically-based pharmacokinetic model. International Journal of Antimicrobial Agents 2015, 45: 413-419.

8.  Decloedt EH, Rosenkranz B, Maartens G, Joska J. Central Nervous system penetration of antiretroviral drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic considerations. Clinical Pharmacokinetics 2015, 54(6): 581-598.

9.  Sy SK, de Kock L, Diacon AH, Werely CJ, Xia H, Rosenkranz B, van der Merwe L, Donald PR. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in drug-resistant pulmonary tuberculosis patients. Antimicrobial Agents in Chemotherapy 2015, 59(7): 4129-4138.

10.  Ying Q, Naidoo S, Vaivars G. Investigation of Activities for Pt-M Bimetallic Nanoparticles Catalysts on the Oxygen Reduction Reaction. Ferroelectrics 484(1): 101-107.

11.  Rosenkranz B, Reid M, Allen E. Medicines development and regulation in Africa. Journal of Medicines Development Sciences 1(2): 33-36.​